Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.

Longeveron Inc., a biotechnology company focused on regenerative medicine, has licensed a US patent from the University of Miami aimed at developing cardiomyogenic precursor cells from pluripotent ...

TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly ...

A woman with a failing heart has been kept alive with the help of a new "breakthrough" stem-cell technology, scientists report. The 46-year-old woman had experienced a heart attack in 2016 and ...

MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric ...

Leading the commercialization of space-age cellular science for personal care products, Naples Soap Company set to the launch nationally a new personal care product line utilizing NASA’s 3D biometric ...

Researchers have developed a capsule-based method that makes it possible to analyze the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...

Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct.